Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Kalina

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|March 29, 2001
Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIbJ Kowalski, B Okopien, A Madej, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2003
Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemiaJ Kowalski, B Okopien, A Madej, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 7, 1998
[Levels of tumor necrosis factor alpha in serum of patients with hyperlipoproteinemia IIB before and after micronized fenofibrate therapy]A Madej, B Okopień, J Kowalski, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 11, 1998
Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIbA Madej, B Okopien, J Kowalski, et al.
Bollettino Chimico Farmaceutico|October 31, 1998
Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertensionZ Kalina, B Okopień, A Madej, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 5, 2002
Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemiaB Okopien, L Cwalina, M Lebek, et al.
Research Communications in Molecular Pathology and Pharmacology|January 5, 2002
A new immunological marker of atherosclerotic injury of arterial wallB Okopień, M Hyper, J Kowalski, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 1, 1995
[Cholecystolithiasis in the urban population of Poland]R Tomecki, J Dzieniszewski, W Gerke, et al.
Research Communications in Molecular Pathology and Pharmacology|February 3, 2005
The risk of atherosclerosis in patients with impaired glucose toleranceB Okopien, A Stachura-Kulach, A Kulach, et al.
Polski Przeglad Radiologii|March 1, 1988
[Report on the 6th European Congress on Radiology, Lisbon, May 31-June 6, 1987]K Niezabitowski, B Pruszyński, J Dobek, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Pharmacology and Therapeutics|March 29, 2001
Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIbJ Kowalski, B Okopien, A Madej, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2003
Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemiaJ Kowalski, B Okopien, A Madej, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 7, 1998
[Levels of tumor necrosis factor alpha in serum of patients with hyperlipoproteinemia IIB before and after micronized fenofibrate therapy]A Madej, B Okopień, J Kowalski, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 11, 1998
Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIbA Madej, B Okopien, J Kowalski, et al.
Bollettino Chimico Farmaceutico|October 31, 1998
Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertensionZ Kalina, B Okopień, A Madej, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 5, 2002
Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemiaB Okopien, L Cwalina, M Lebek, et al.
Research Communications in Molecular Pathology and Pharmacology|January 5, 2002
A new immunological marker of atherosclerotic injury of arterial wallB Okopień, M Hyper, J Kowalski, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 1, 1995
[Cholecystolithiasis in the urban population of Poland]R Tomecki, J Dzieniszewski, W Gerke, et al.
Research Communications in Molecular Pathology and Pharmacology|February 3, 2005
The risk of atherosclerosis in patients with impaired glucose toleranceB Okopien, A Stachura-Kulach, A Kulach, et al.
Polski Przeglad Radiologii|March 1, 1988
[Report on the 6th European Congress on Radiology, Lisbon, May 31-June 6, 1987]K Niezabitowski, B Pruszyński, J Dobek, et al.
Pageof 10